FI77157C - Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen. - Google Patents

Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen. Download PDF

Info

Publication number
FI77157C
FI77157C FI822325A FI822325A FI77157C FI 77157 C FI77157 C FI 77157C FI 822325 A FI822325 A FI 822325A FI 822325 A FI822325 A FI 822325A FI 77157 C FI77157 C FI 77157C
Authority
FI
Finland
Prior art keywords
gra
cells
lectin
cancer
antigen
Prior art date
Application number
FI822325A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI822325L (fi
FI77157B (fi
FI822325A0 (fi
Inventor
Masakazu Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of FI822325A0 publication Critical patent/FI822325A0/fi
Publication of FI822325L publication Critical patent/FI822325L/fi
Application granted granted Critical
Publication of FI77157B publication Critical patent/FI77157B/fi
Publication of FI77157C publication Critical patent/FI77157C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FI822325A 1981-10-01 1982-06-29 Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen. FI77157C (fi)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP15641481 1981-10-01
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP15641381 1981-10-01
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP15847381 1981-10-05
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP15847281 1981-10-05
JP11116882 1982-06-28
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (4)

Publication Number Publication Date
FI822325A0 FI822325A0 (fi) 1982-06-29
FI822325L FI822325L (fi) 1983-04-02
FI77157B FI77157B (fi) 1988-10-31
FI77157C true FI77157C (fi) 1989-02-10

Family

ID=27526479

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822325A FI77157C (fi) 1981-10-01 1982-06-29 Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.

Country Status (19)

Country Link
AR (1) AR230731A1 (forum.php)
AT (2) AT382080B (forum.php)
AU (1) AU554858B2 (forum.php)
BE (1) BE893704A (forum.php)
CA (1) CA1195269A (forum.php)
CH (2) CH655660B (forum.php)
DD (2) DD221917A5 (forum.php)
DE (2) DE3236298A1 (forum.php)
DK (1) DK292182A (forum.php)
FI (1) FI77157C (forum.php)
FR (1) FR2513882B1 (forum.php)
IL (1) IL66270A (forum.php)
IT (1) IT1189305B (forum.php)
MX (1) MX7437E (forum.php)
NL (1) NL8202638A (forum.php)
NO (1) NO161601C (forum.php)
NZ (1) NZ201112A (forum.php)
PT (1) PT75148B (forum.php)
SE (1) SE8204058L (forum.php)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Also Published As

Publication number Publication date
SE8204058L (sv) 1983-04-02
DK292182A (da) 1983-04-02
DE3236298A1 (de) 1984-03-15
MX7437E (es) 1988-11-14
NO161601C (no) 1989-09-06
DE3249568C2 (forum.php) 1987-10-01
CA1195269A (en) 1985-10-15
IT8248724A1 (it) 1983-12-30
AU554858B2 (en) 1986-09-04
FR2513882B1 (fr) 1986-04-04
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
FI822325L (fi) 1983-04-02
DE3249568A1 (de) 1985-02-07
ATA363782A (de) 1986-06-15
CH655660B (forum.php) 1986-05-15
AT390002B (de) 1990-03-12
NZ201112A (en) 1986-10-08
ATA354585A (de) 1989-08-15
PT75148A (en) 1982-07-01
PT75148B (en) 1986-08-14
IT1189305B (it) 1988-02-04
CH655661B (forum.php) 1986-05-15
AR230731A1 (es) 1984-06-29
FR2513882A1 (fr) 1983-04-08
FI77157B (fi) 1988-10-31
NO822215L (no) 1983-04-05
DD209577A5 (de) 1984-05-16
NL8202638A (nl) 1983-05-02
IT8248724A0 (it) 1982-06-30
AT382080B (de) 1987-01-12
NO161601B (no) 1989-05-29
IL66270A0 (en) 1982-11-30
DD221917A5 (de) 1985-05-08
IL66270A (en) 1986-03-31
DE3236298C2 (forum.php) 1987-09-24
SE8204058D0 (sv) 1982-06-30
FI822325A0 (fi) 1982-06-29

Similar Documents

Publication Publication Date Title
FR2522267A1 (fr) Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique
GB2106935A (en) Cancer cell-combatting lymphocytes process, for the production thereof, and anticancer agents containing said lymphocytes
GB2086392A (en) Preparation controlling t-system of immunity and method for producing same
KR950008767B1 (ko) 에브셀렌(Ebselen)의 새로운 의약적 용도
KR920002935B1 (ko) 맥관 형성 저해제
FI77157C (fi) Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
EP0129173A2 (en) Malaria associated antigen and preparing process thereof
RU2205010C2 (ru) Природные противоопухолевые или противовирусные вещества и их применение
AU758856C (en) Compositions containing muscle-derived active agents
FI80711B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar termiskt denaturerad, till en glykosidbindning ansluten antigen (gra), som haerroer sig fraon cancerceller.
Fisher et al. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition
CA1201988A (en) Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes
SU1412596A3 (ru) Способ получени цитотоксических к раковым клеткам лимфоцитов и способ получени гликосв занного антигена
KR880001758B1 (ko) 암세포에 대항하는 임파구의 제조방법
US20090227488A1 (en) Class of bioactive glycoprotein
EP0134247A1 (en) Protein with oncostatic effect, process for its preparation, and oncostatic drug containing it
WO2000043403A1 (en) 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
JPS63164895A (ja) 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
NZ214000A (en) Method of sensitising lymphocytes to cancer associated antigens
Kedar et al. Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell cultures
KR100673565B1 (ko) 인터페론-감마의 항암작용 개선제 및 상기 항암작용 개선제와 인터페론-감마를 유효성분으로 함유하는 항암제용 조성물
Tibell et al. Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.
FR2492663A1 (fr) Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation
JP3660230B2 (ja) 天然型抗腫瘍性又は抗ウイルス性物質およびその用途

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: OTSUKA PHARMACEUTICAL CO,_. LTD.